Back
Virtus AllianzGI Diversified Income & Convertible Fund Vs. Novo Nordisk AS Industry Stock Comparison
Sell
36
ACV
Virtus AllianzGI Diversified Income & Convertible Fund
Last Price:
$22.01
Seasonality Move:
-5.57%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
36
Virtus AllianzGI Diversified Income & Convertible Fund (ACV)
is a Sell
Is Virtus AllianzGI Diversified Income & Convertible Fund a Buy, Sell or Hold?
-
The current Virtus AllianzGI Diversified Income & Convertible Fund [ACV] share price is $21.99. The Score for ACV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
ACV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACV Stock Price Chart
What is Virtus AllianzGI Diversified Income & Convertible Fund's stock price today?
-
The Virtus AllianzGI Diversified Income & Convertible Fund share price today is $21.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACV is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
ACV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 43.06 | Sell |
Chaikin Money Flow: | 14562 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.97 - 22.99) | Sell |
Bollinger Bands (100): | (20.76 - 22.22) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 19.69 | Sell |
Chaikin Money Flow: | 20899665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.63 - 110.99) | Sell |
Bollinger Bands (100): | (107.27 - 131.41) | Sell |
ACV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.54 | Sell |
20-day SMA: | 22.66 | Sell |
50-day SMA: | 21.94 | Buy |
200-day SMA: | 21.77 | Buy |
8-day EMA: | 22.38 | Sell |
20-day EMA: | 22.45 | Sell |
50-day EMA: | 22.09 | Sell |
200-day EMA: | 21.53 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.71 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 109.28 | Sell |
200-day SMA: | 126.25 | Sell |
8-day EMA: | 102.07 | Sell |
20-day EMA: | 105.53 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 118.09 | Sell |
Virtus AllianzGI Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Virtus AllianzGI Diversified Income & Convertible Fund Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |